CASI Pharmaceuticals
CASI
#9680
Rank
A$61.76 M
Marketcap
$3.99
Share price
-5.66%
Change (1 day)
-47.51%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -A$44.32 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$22.05 Million. In 2023 the company made an earning of -A$42.06 Million, an increase over its 2022 earnings that were of -A$59.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$44.32 Million5.37%
2023 -A$42.06 Million-29.55%
2022 -A$59.7 Million4.43%
2021 -A$57.16 Million-24.56%
2020 -A$75.77 Million4.74%
2019 -A$72.35 Million65.13%
2018 -A$43.81 Million155.07%
2017 -A$17.18 Million13.93%
2016 -A$15.08 Million31.18%
2015 -A$11.5 Million-72.5%
2014 -A$41.79 Million356.62%
2013 -A$9.16 Million-60.55%
2012 -A$23.2 Million218.41%
2011 -A$7.29 Million0.74%
2010 -A$7.24 Million-32.54%
2009 -A$10.72 Million-66.98%
2008 -A$32.47 Million-14.22%
2007 -A$37.85 Million7.04%
2006 -A$35.36 Million27.95%
2005 -A$27.64 Million4.51%
2004 -A$26.45 Million-15.84%
2003 -A$31.42 Million-55.29%
2002 -A$70.28 Million-34.05%
2001 -A$0.11 Billion31.73%
2000 -A$80.89 Million31.56%
1999 -A$61.49 Million145.56%
1998 -A$25.04 Million76.4%
1997 -A$14.2 Million36.92%
1996 -A$10.37 Million